Immediate skin-to-skin care for preterm infants after birth
Run by Medical University of Graz · NCT06794164 · Data updated 2026-11-12
This study tests if giving preterm babies skin-to-skin contact with their mothers right after birth helps improve their health and development compared to waiting 24 hours.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 0 Minutes to 30 Minutes |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Medical University of Graz Academic / other |
| Locations | 1 site (Graz, Styria) |
| Status | Recruiting |
| Started | February 3, 2025 |
| Main results expected | February 3, 2027 |
| Study ends | February 3, 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT06794164 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are preterm infants born between 26 and 32 weeks of gestation whose parents can provide informed consent.
✕Probably not a fit
Patients who are not intended for full life support or have severe congenital malformations may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the feasibility, safety, and effects of immediate skin-to-skin contact for preterm infants born between 26 and 32 weeks of gestation. The intervention involves providing skin-to-skin care right after birth, compared to standard care which allows for contact within 24 hours. The aim is to determine the benefits of this early contact for both the infants and their mothers. The study will assess various outcomes related to the health and development of the preterm neonates.
Why it matters
Potential benefit: If successful, this approach could enhance the health outcomes of preterm infants and improve maternal bonding.
How similar studies have gone: Previous studies have shown positive outcomes with skin-to-skin care in preterm infants, suggesting this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gestational age between 26+0 and 32+0 weeks * Written parental informed consent Exclusion Criteria: * No intention of full life support * Severe congenital malformation
Where it's running
-
Medical University of Graz
Graz, Styria, Austria Recruiting
Study contacts
- Study coordinator: Nariae Baik-Schneditz, MD, PhD
- Email: nariae.baik@medunigraz.at
- Phone: +4331638582677
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Skin conductance monitoring for premature infants on ventilators.
We will try tiny electrodes on a premature baby's foot to see if changes in skin conductance reflect pain from different ventilator settings and whether skin-to-skin care lowers that stress.
-
Skin-to-skin care with the Skincubator for preterm infants
This study tests whether using the Skincubator during skin-to-skin care is safe and feasible for preterm babies and their parents in the NICU.
-
Topical nicotinamide riboside for facial aging Signs
A topical niacinamide riboside product is being tested to see if it reduces signs of aging on the face in adults 30–60.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.